This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Aspen API


At Aspen API, your C(D)MO API project is in excellent hands. Being a high-quality partner and having well-equipped pilot laboratories, pilot plants and cGMP facilities, we collaborate with you to ensure success. We have a 100-year history in development, up-scaling and commercially manufacturing of complex HPAPIs, peptides, narcotics and other APIs.

At our site in Oss, the Netherlands, we have established extensive experience and a solid reputation of producing cGMP peptides with batch-to-batch reproducibility combined with high yields and high purity profiles. We have extensive know-how and experience in both solution and solid-phase synthesis. In addition, we have a green method for the large-scale manufacturing of peptides in solution (Green Continuous LPPS™).

Should you wish to require more information, do not hesitate to reach out at